These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19004944)

  • 1. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
    Noriega VM; Tortorella D
    J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
    Chevalier MS; Johnson DC
    J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus US3 modulates destruction of MHC class I molecules.
    Noriega VM; Hesse J; Gardner TJ; Besold K; Plachter B; Tortorella D
    Mol Immunol; 2012 Jun; 51(2):245-53. PubMed ID: 22497807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
    Chevalier MS; Daniels GM; Johnson DC
    J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
    Jones TR; Wiertz EJ; Sun L; Fish KN; Nelson JA; Ploegh HL
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11327-33. PubMed ID: 8876135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum chaperones participate in human cytomegalovirus US2-mediated degradation of class I major histocompatibility complex molecules.
    Oresic K; Tortorella D
    J Gen Virol; 2008 May; 89(Pt 5):1122-1130. PubMed ID: 18420789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
    Oresic K; Ng CL; Tortorella D
    J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
    Pande NT; Powers C; Ahn K; Früh K
    J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
    Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
    J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.
    Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M
    J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.
    Jones TR; Sun L
    J Virol; 1997 Apr; 71(4):2970-9. PubMed ID: 9060656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form.
    Shin J; Park B; Lee S; Kim Y; Biegalke BJ; Kang S; Ahn K
    J Virol; 2006 Jun; 80(11):5397-404. PubMed ID: 16699020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
    Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
    J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity.
    Han J; Rho SB; Lee JY; Bae J; Park SH; Lee SJ; Lee SY; Ahn C; Kim JY; Chun T
    Mol Cells; 2013 Nov; 36(5):455-64. PubMed ID: 24213674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus: host immune modulation by the viral US3 gene.
    Liu Z; Winkler M; Biegalke B
    Int J Biochem Cell Biol; 2009 Mar; 41(3):503-6. PubMed ID: 18992841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structural determinant of human cytomegalovirus US2 dictates the down-regulation of class I major histocompatibility molecules.
    Oresic K; Noriega V; Andrews L; Tortorella D
    J Biol Chem; 2006 Jul; 281(28):19395-406. PubMed ID: 16687410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
    Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
    J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner.
    Gewurz BE; Wang EW; Tortorella D; Schust DJ; Ploegh HL
    J Virol; 2001 Jun; 75(11):5197-204. PubMed ID: 11333901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.